1997
DOI: 10.1016/s0378-5955(97)00154-8
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
67
0
5

Year Published

2002
2002
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 116 publications
(75 citation statements)
references
References 44 publications
3
67
0
5
Order By: Relevance
“…It is well known that glutathione and glutathione-related enzymes protect against oxidative cell injury caused by free radicals. Specific changes in glutathione levels and enzymes in glutathione metabolism have been found with cisplatin treatment [14] . These findings are in agreement with the proposed mechanism of action based on oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that glutathione and glutathione-related enzymes protect against oxidative cell injury caused by free radicals. Specific changes in glutathione levels and enzymes in glutathione metabolism have been found with cisplatin treatment [14] . These findings are in agreement with the proposed mechanism of action based on oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…Insults such as neurotrophin withdrawal, ototoxin exposure, and hypoxia/ischemia lead to oxidative stress, which then leads to apoptosis [Lautermann et al, 1997]. Reactive oxygen species (ROS) including free radicals are formed as by-products of several metabolic pathways and these molecules can themselves cause cell damage by reacting with cellular proteins, lipids and DNA.…”
Section: Reactive Oxygen Speciesmentioning
confidence: 99%
“…PBN is able to form adducts with ROS thereby reducing the likelihood of oxidative stress. The role of oxidative stress in cochlear injury has also been underscored as a consequence of aminoglycoside antibiotic (Garetz et al 1994;Hester et al 1998;Lautermann et al 1997) and cisplatin (Rybak et al 1995Campbell et al 1996Campbell et al , 1999Kopke et al 1997;Dehne et al 2001). Both of these agents are widely recognized as promoting NIHL (e.g., Bone and Ryan 1978;Brown et al 1980;Bhattacharyya and Dayal 1991;Gratton et al 1990).…”
Section: Introductionmentioning
confidence: 99%